Wagner, L., Abonour, R., Ailawadhi, S., Durie, B. G. M., Gasparetto, C. J., Hardin, J. W., … Jagannath, S. (2021). P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry. In Clinical Lymphoma Myeloma and Leukemia (Vol. 21, pp. S109–S109). Elsevier BV. https://doi.org/10.1016/s2152-2650(21)02263-1

Wagner, Lynne, Rafat Abonour, Sikander Ailawadhi, Brian G. M. Durie, Cristina J. Gasparetto, James W. Hardin, Hans Lee, et al. “P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.” In Clinical Lymphoma Myeloma and Leukemia, 21:S109–S109. Elsevier BV, 2021. https://doi.org/10.1016/s2152-2650(21)02263-1.

Wagner L, Abonour R, Ailawadhi S, Durie BGM, Gasparetto CJ, Hardin JW, et al. P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry. In: Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2021. p. S109–S109.

Wagner, Lynne, et al. “P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.” Clinical Lymphoma Myeloma and Leukemia, vol. 21, Elsevier BV, 2021, pp. S109–S109. Crossref, doi:10.1016/s2152-2650(21)02263-1.

Wagner L, Abonour R, Ailawadhi S, Durie BGM, Gasparetto CJ, Hardin JW, Lee H, Narang M, Rifkin R, Terebelo H, Toomey K, Joshi P, Agarwal A, Braverman J, Dhanda DS, He M, Jagannath S. P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry. Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2021. p. S109–S109.